New Zealand markets closed

Kala Pharmaceuticals Inc (27F0.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
6.90+0.89 (+14.81%)
At close: 08:08PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-39,551
-42,199
-44,822
-142,605
-104,327
Depreciation & amortisation
292
303
537
975
912
Stock-based compensation
8,515
7,463
7,008
16,088
13,312
Change in working capital
5,435
8,895
491
-10,616
-3,573
Accounts receivable
-2
78
15,138
-5,756
1,959
Inventory
5,355
7,544
1,708
-6,257
-2,368
Accounts payable
-265
-1,904
-2,076
3,231
-924
Other working capital
-29,602
-28,537
-79,221
-113,774
-92,636
Other non-cash items
-3,778
-2,389
2,290
22,528
2,987
Net cash provided by operating activities
-29,087
-27,927
-78,908
-108,235
-90,694
Cash flows from investing activities
Investments in property, plant and equipment
-515
-610
-313
-5,539
-1,942
Acquisitions, net
-
-
-
-4,653
0
Purchases of investments
-
-9,866
-4,992
0
-113,592
Sales/maturities of investments
-
10,000
5,000
76,250
37,325
Net cash used for investing activities
-334
-429
62,717
70,803
-78,209
Cash flows from financing activities
Debt repayment
0
-10,000
-40,039
-78,045
-32
Common stock issued
3,643
18,536
31,796
41,232
158,557
Other financing activities
-119
-2,041
-
-
-
Net cash used provided by (used for) financing activities
14,088
8,506
-7,942
42,554
160,628
Net change in cash
-15,333
-19,850
-24,133
5,122
-8,275
Cash at beginning of period
63,811
70,745
94,878
89,756
98,031
Cash at end of period
48,478
50,895
70,745
94,878
89,756
Free cash flow
Operating cash flow
-29,087
-27,927
-78,908
-108,235
-90,694
Capital expenditure
-515
-610
-313
-5,539
-1,942
Free cash flow
-29,602
-28,537
-79,221
-113,774
-92,636